Megan Parsi

Megan Parsi has extensive experience in Regulatory Affairs, having worked in the field since 2003. Megan started their career at Celgene as Director, Regulatory Affairs in 2003, and then moved to Asubio Pharmaceuticals in 2012 in the same role. In 2013, they joined Otsuka Pharmaceutical Co., Ltd. as Director, Regulatory Affairs, and then moved to Actavis (now Allergan) in 2015 as a Regulatory Strategy Consultant. In the same year, they joined Turing Pharmaceuticals AG as Director Regulatory Affairs. In 2016, they worked as a Clinical and Regulatory Consultant at Oxford International, and then joined Sellas Life Sciences as Sr. Regulatory Director/Consultant. Megan then started their own company, MP Regulatory Consulting, as Principal Consultant. In 2017, they joined Oncolytics Biotech Inc. as Executive Director, and they are currently working in the same role at Advaxis, Inc.

Megan Parsi earned a Bachelor's degree in Chemical Engineering from the New Jersey Institute of Technology and a MBS from Rutgers University in the field of Pharmaceuticals/Biotech Drug Discovery and Development. Megan also holds a Mini-MBA certification from The Satellite Centers.